Indications and uses
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches menstrual cramps toothache backache headache the common cold temporarily reduces fever
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches menstrual cramps toothache backache headache the common cold temporarily reduces fever
do not take more than directed the smallest effective dose should be used drink a full glass of water with each dose Adults and children 12 years and older take 1 caplet every 8 to 12 hours while symptoms last for the first dose you may take 2 caplets within the first hour do not exceed 2 caplets in any 8 to 12 hour period do not exceed 3 caplets in a 24 hour period Children under 12 years ask a doctor
each caplet contains: sodium 20 mg store at 20° to 25°C (68° to 77°F). Avoid high humidity and excessive heat above 40°C (104°F).
Drug Facts
Naproxen sodium USP 220 mg (naproxen 200 mg) (NSAID)*
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| Adults and children 12 years and older |
|
| Children under 12 years |
|
colloidal silicon dioxide, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide
1-888-287-1915
DISTRIBUTED BY:
Walmart Inc.,
Bentonville, AR 72716
PRODUCT OF INDIA
**This product is not manufactured or distributed by
Bayer HealthCare LLC, distributor of Aleve® Caplets.
NDC 79903-232-90
equate™
Compare
to Aleve®
Caplets
active
ingredient**
All Day
Pain Relief
Naproxen Sodium
Tablets USP, 220 mg
(NSAID)
Pain Reliever/
Fever Reducer
Strength to 12
Last 12 Hours HOURS
220 90
mg CAPLETS†
EACH
Actual Size †Capsule-Shaped Tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79903-232-90 | Naproxen Sodium | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 4 | |
| 79903-232-90 | Naproxen Sodium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 79903-232 | 79903-232-90 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NAPROXEN SODIUM | 9TN87S3A3C | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| FD&C BLUE NO. 2 | L06K8R7DQK | IACT |
| HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL 8000 | Q662QK8M3B | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205497-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A205497-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2016-03-18 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A205497-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2016-03-18 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A205497-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2016-03-18 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | WALMART INC. | 1292c0ca-343e-adcc-e063-6394a90ab9fa | 2025-05-23 | Warnings | 79903-232-90 79903-232 79903023290 9641a476-de98-47f1-b608-d687aaba9e42 1292c0ca-343e-adcc-e063-6394a90ab9fa |
Adverse event summaries are temporarily unavailable. Other product information remains available.